Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S0896 |
Loureirin A
龙血素 A,龙血素A |
Akt; PI3K | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
Loureirin A 是一种黄酮类物质,从龙血树中分离得到,能够降低Akt 的磷酸化,具有抗血小板聚集作用。 | |||
TN1517 |
1-(2,6-dimethoxyphenyl)-3-(4-hydroxyphenyl)propan-1-one
剑叶龙血素A,Cochinchinenin A |
Others | Others |
1-(2,6-dimethoxyphenyl)-3-(4-hydroxyphenyl)propan-1-one (Cochinchinenin A) 是龙血镇痛作用的物质基础。 | |||
TN2345 |
Loureirin D
|
Others | Others |
Loureirin D 是一种来自 Dracaena cochinchinensis 草药的查尔酮。 | |||
TN1878 |
Loureirin D
Loureirin D,4,4'-Dihydroxy-2,6-dimethoxydihydrochalcone |
Others | Others |
Loureirin D (4,4'-Dihydroxy-2,6-dimethoxydihydrochalcone) 是从 Dracaena loureiri 的茎木中分离出来的。 | |||
TN1054 |
Loureirin C
龙血素C,龙血素 C |
Others | Others |
Loureirin C 在体外能有效抑制凝血酶的活性。它具有抗菌,抗痉挛,抗炎,止痛,抗糖尿病和抗肿瘤作用。 | |||
T3876 |
Loureirin B
龙血素B,龙血素 B |
PAI-1; ERK; Potassium Channel; JNK | MAPK; Membrane transporter/Ion channel; Metabolism |
Loureirin B 是从剑叶龙血树中分离到的一种黄酮,是 PAI-1抑制剂,IC50值为 26.10 μM。它抑制 KATP,以及 ERK 和 JNK 的磷酸化,具有抗糖尿病的功效。 | |||
TN1518 | Cochinchinenin C | Others | Others |
There is a synergistic interaction between loureirin A and Cochinchinenin C, and the fluorescence quenching of HSA by loureirin A (or Cochinchinenin C) is a combined quenching procedure (dynamic and static quenching). |